The Lawrence native got to hear some cheers for his efforts on the rival's home court, all for a good cause.
Surveyed oncologists reported high likelihood to prescribe (6 of 7), citing deep remissions, transplant-bridging potential, ...
New research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational ...
HOUSTON, June 04, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin” or the "Company”), today announced that Walter Klemp, Chairman and Chief Executive Officer of Moleculin, ...
The ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia ...
Researchers sought to determine whether adding selinexor to chemotherapeutic induction and consolidation regimen would improve outcomes in AML.
Need a quote from a Motley Fool analyst? Total Revenue -- $24 million, a 30% increase, attributed chiefly to expansion in ...
Caroline Kennedy became emotional when talking about her daughter, Tatiana Schlossberg, who died this past December. Kennedy was speaking at the John F. Kennedy Profile in Courage Award ceremony held ...
Independent Cleveland Clinic Cardiac Review Supports Potential Best-in-Class Safety Profile as MIRACLE Phase 2b/3 Trial AdvancesHOUSTON, May 29, ...
Fast track status supports expedited development/review for a serious hematologic malignancy with limited second-line therapy after HMA failure. CyTAC engineering merges small-molecule CCR2 binding ...
Solu Therapeutics, a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, ...
Concomitant systemic mastocytosis (SM) can complicate acute myeloid leukaemia (AML) with t(8;21) and its recognition, particularly in the presence of KIT D816 mutations, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results